2m 2m 2m 2m 2m 2m 2m
TREES (CANN)
OTC
$0.02+$0.002 (+11.88%)
Price as of Jun 03, 2026- $2.2MMarket Cap
- -27.68%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TREES (CANN)
$0.02+$0.002 (+11.88%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 18.1M +34.90% | 13.4M +126.83% | 5.9M -16.75% | 7.1M N/A | |
Cost of Revenue | 11.6M +34.82% | 8.6M +93.21% | 4.4M -18.80% | 5.5M N/A | |
Gross Profit | 6.6M +35.04% | 4.9M +227.15% | 1.5M -9.99% | 1.7M N/A | |
Sales and Marketing Expense | 8.2M +25.39% | 6.6M +137.20% | 2.8M -25.26% | 3.7M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 874,412 +163.87% | 331,376 -35.27% | 511,933 +135.23% | 217,635 N/A | |
Total Operating Expenses | 22.1M +33.05% | 16.6M +85.90% | 8.9M -32.20% | 13.2M N/A | |
Operating Profit | -4.0M +25.19% | -3.2M +5.37% | -3.0M -50.33% | -6.1M N/A | |
Interest Income | N/A N/A | 132,979 0.00% | 132,979 +35.76% | 97,948 N/A | |
Interest Expense | -1.8M +79.36% | -983,181 +57.95% | -622,469 +37.25% | -453,522 N/A | |
Interest Income and Expense and Net | -1.8M +107.41% | -850,202 +73.69% | -489,490 +37.66% | -355,574 N/A | |
Total Nonoperating Income and Expense | -2.9M -52.14% | -6.1M +12.68% | -5.4M +248.62% | -1.6M N/A | |
Income before Taxes | -6.9M -25.67% | -9.3M +10.07% | -8.4M +10.61% | -7.6M N/A | |
Income Taxes | 187,848 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 1.5M -49.54% | 3.0M -0.20% | 3.0M N/A | N/A N/A | |
Net Income | -7.1M -25.25% | -9.5M +6.83% | -8.9M +15.49% | -7.7M N/A | |
Net Income from Continuing Operations Applicable to Common | -7.1M -25.95% | -9.6M +7.83% | -8.9M +4.22% | -8.5M N/A | |
Basic EPS and Net Income | -0.06 -40.00% | -0.10 -23.08% | -0.13 -23.53% | -0.17 N/A | |
Diluted EPS and Net Income | -0.06 -40.00% | -0.10 -23.08% | -0.13 -23.53% | -0.17 N/A | |
Basic Weighted Average Shares | 117.2M +20.61% | 97.2M +39.73% | 69.5M +36.63% | 50.9M N/A | |
Diluted Weighted Average Shares | 117.2M +20.61% | 97.2M +39.73% | 69.5M +36.63% | 50.9M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 969,676 -62.47% | 2.6M +25.79% | 2.1M +173.79% | 750,218 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 969,676 -62.47% | 2.6M +25.79% | 2.1M +173.79% | 750,218 N/A | |
Total Current Assets | 2.4M -52.45% | 5.0M +42.31% | 3.5M +36.46% | 2.5M N/A | |
Accumulated Depreciation | 685,625 +63.28% | 419,903 +8.54% | 386,870 +59.72% | 242,223 N/A | |
Property and Plant and Equipment and Net | 1.4M -28.38% | 1.9M +186.33% | 680,327 +49.45% | 455,222 N/A | |
Total Long-Term Assets | 1.4M -28.38% | 1.9M +186.33% | 680,327 +49.45% | 455,222 N/A | |
Total Assets | 23.2M -26.65% | 31.7M +43.91% | 22.0M +158.54% | 8.5M N/A | |
Income Taxes Payable | 392,765 +91.67% | 204,917 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.1M -42.61% | 1.9M +73.92% | 1.1M -53.04% | 2.3M N/A | |
Total Current Liabilities | 7.4M +19.95% | 6.1M +50.46% | 4.1M +30.38% | 3.1M N/A | |
Total Long-Term Debt | 14.0M -11.86% | 15.9M +169.13% | 5.9M +104.53% | 2.9M N/A | |
Total Long-Term Liabilities | 15.2M -17.40% | 18.4M +129.16% | 8.0M +96.36% | 4.1M N/A | |
Total Liabilities | 23.1M -8.66% | 25.3M +103.66% | 12.4M +65.16% | 7.5M N/A | |
Retained Earnings | -100.5M +7.60% | -93.4M +11.41% | -83.8M +11.83% | -75.0M N/A | |
Total Stockholders Equity | 148,159 -97.69% | 6.4M -33.32% | 9.6M +860.00% | 1.0M N/A | |
Total Shares Outstanding | 108.7M -8.36% | 118.7M +32.51% | 89.6M +47.26% | 60.8M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -1.1M -45.09% | -2.0M -22.70% | -2.7M -46.97% | -5.0M N/A | |
Capital Expenditures | N/A N/A | 61,611 -81.43% | 331,834 +5.42% | 314,771 N/A | |
Cash from Investing Activities | -304,420 -84.35% | -1.9M +98.78% | -978,739 -188.40% | 1.1M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -184,255 -104.07% | 4.5M -8.19% | 4.9M +11.41% | 4.4M N/A | |
Financials Ratio | |||||
Gross Margin | 36.24% +0.10% | 36.20% +44.23% | 25.10% +8.12% | 23.21% N/A | |
Operating Margin | -21.91% -7.20% | -23.61% -53.54% | -50.83% -40.33% | -85.19% N/A | |
Return on Assets | -25.78% -26.92% | -35.28% -39.26% | -58.08% -54.55% | -127.77% N/A | |
Return on Equity | -216.10% +82.62% | -118.33% -29.23% | -167.21% -151.86% | 322.44% N/A | |
Revenue Growth | 34.90% -72.48% | 126.83% +857.03% | -16.75% -117.78% | 94.20% N/A | |
Current Ratio | 0.32 -60.35% | 0.81 -5.41% | 0.85 +4.65% | 0.81 N/A | |
Cash Ratio | 0.13 -68.70% | 0.42 -16.39% | 0.50 +109.97% | 0.24 N/A | |
Debt-to-Equity Ratio | 101.96 +3,569.07% | 2.78 +281.30% | 0.73 -86.02% | 5.21 N/A | |
Debt-to-Assets Ratio | 0.65 +15.68% | 0.56 +76.69% | 0.32 -48.11% | 0.61 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow